In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
I am a U.S. Healthcare Professional
I am a U.S. Patient / Caregiver
I am a U.S. Patient / CaregiverSelect
Non-US residents click here.


ELREXFIO Before receiving ELREXFIO, tell your healthcare provider about all of your medical conditions, including if you:

(elranatamab-bcmm)

Before receiving ELREXFIO, tell your healthcare provider about all of your medical conditions, including if you:

•
have an infection.
•
are pregnant or plan to become pregnant. ELREXFIO may harm your unborn baby.
Females who are able to become pregnant:
o
Your healthcare provider should do a pregnancy test before you start treatment with ELREXFIO.
o
You should use effective birth control (contraception) during treatment and for 4 months after your last dose of ELREXFIO.
o
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with ELREXFIO.
•
are breastfeeding or plan to breastfeed. It is not known if ELREXFIO passes into your breast milk. Do not breastfeed during treatment and for 4 months after your last dose of ELREXFIO.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Find ELREXFIO medical information:

Find ELREXFIO medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ELREXFIO Quick Finder

Health Professional Information

Before receiving ELREXFIO, tell your healthcare provider about all of your medical conditions, including if you:

Before receiving ELREXFIO, tell your healthcare provider about all of your medical conditions, including if you:

•
have an infection.
•
are pregnant or plan to become pregnant. ELREXFIO may harm your unborn baby.
Females who are able to become pregnant:
o
Your healthcare provider should do a pregnancy test before you start treatment with ELREXFIO.
o
You should use effective birth control (contraception) during treatment and for 4 months after your last dose of ELREXFIO.
o
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with ELREXFIO.
•
are breastfeeding or plan to breastfeed. It is not known if ELREXFIO passes into your breast milk. Do not breastfeed during treatment and for 4 months after your last dose of ELREXFIO.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Download Prescribing Information

Health Professional Information

Before receiving ELREXFIO, tell your healthcare provider about all of your medical conditions, including if you:

Before receiving ELREXFIO, tell your healthcare provider about all of your medical conditions, including if you:

•
have an infection.
•
are pregnant or plan to become pregnant. ELREXFIO may harm your unborn baby.
Females who are able to become pregnant:
o
Your healthcare provider should do a pregnancy test before you start treatment with ELREXFIO.
o
You should use effective birth control (contraception) during treatment and for 4 months after your last dose of ELREXFIO.
o
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with ELREXFIO.
•
are breastfeeding or plan to breastfeed. It is not known if ELREXFIO passes into your breast milk. Do not breastfeed during treatment and for 4 months after your last dose of ELREXFIO.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.